Cargando…

Anticancer Dose Adjustment for Patients with Renal and Hepatic Dysfunction: From Scientific Evidence to Clinical Application

Most anticancer agents exhibit a narrow therapeutic index, i.e., a small change in plasma concentrations can lead to a less efficacious treatment or an unacceptable degree of toxicity. This study aimed at providing health professionals with a feasible and time-saving tool to adapt the dose of antica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hendrayana, Tomi, Wilmer, André, Kurth, Verena, Schmidt-Wolf, Ingo GH, Jaehde, Ulrich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388145/ https://www.ncbi.nlm.nih.gov/pubmed/28264440 http://dx.doi.org/10.3390/scipharm85010008

Ejemplares similares

The effect of a Clinical Decision Support System on the frequency of dose adjustments of anticancer drugs in case of renal or hepatic dysfunction
por: Rolvink, José, et al.
Publicado: (2021)

Evaluation of body-surface-area adjusted dosing of high-dose methotrexate by population pharmacokinetics in a large cohort of cancer patients
por: Arshad, Usman, et al.
Publicado: (2021)

Effect of chaetocin on renal cell carcinoma cells and cytokine-induced killer cells
por: Rombo, Roman, et al.
Publicado: (2016)

The Rate of Antibiotic Dosage Adjustment in Renal Dysfunction
por: Fahimi, Fanak, et al.
Publicado: (2012)

Computational analysis of heat shock proteins and ferroptosis-associated lncRNAs to predict prognosis in acute myeloid leukemia patients
por: Ge, Fangfang, et al.
Publicado: (2023)

Developing tumor-specific PRO-CTCAE item sets: analysis of a cross-sectional survey in three German outpatient cancer centers
por: Günther, Maximilian, et al.
Publicado: (2023)

Increase in Efficacy of Checkpoint Inhibition by Cytokine-Induced-Killer Cells as a Combination Immunotherapy for Renal Cancer
por: Dehno, Mojgan Naghizadeh, et al.
Publicado: (2020)

Dose Adjustment of Poly (ADP‑Ribose) Polymerase Inhibitors in Patients with Hepatic or Renal Impairment
por: Zhao, Dehua, et al.
Publicado: (2022)

Individualised dosing strategy for high-dose carboplatin in patients with germ cell cancer
por: Kloft, C, et al.
Publicado: (2003)

Cytokine-Induced Killer Cells in Combination with Heat Shock Protein 90 Inhibitors Functioning via the Fas/FasL Axis Provides Rationale for a Potential Clinical Benefit in Burkitt’s lymphoma
por: Ge, Fangfang, et al.
Publicado: (2023)

Enhancing adherence to capecitabine chemotherapy by means of multidisciplinary pharmaceutical care
por: Simons, Sven, et al.
Publicado: (2010)

Polymyxin B in Patients With Renal Impairment: Is It Necessary to Adjust Dose?
por: Nie, Ruifang, et al.
Publicado: (2022)

High dose chemotherapy with autologous stem cell transplantation in diffuse large B-cell lymphoma
por: Mey, Ulrich J.M., et al.
Publicado: (2007)

Thromboprophylaxis in COVID‐19: Weight and severity adjusted intensified dosing
por: Engelen, Matthias M., et al.
Publicado: (2022)

Natural Killer T Cells Subsets in Cancer, Functional Defects in Prostate Cancer and Implications for Immunotherapy
por: Nowak, Michael, et al.
Publicado: (2011)

High-dose chemotherapy with autologous peripheral blood stem cell support for recurrent primary AFP-producing intracranial germinoma
por: Ziske, Carsten, et al.
Publicado: (2003)

Measuring Co-Authorship and Networking-Adjusted Scientific Impact
por: Ioannidis, John P. A.
Publicado: (2008)

Indispensable Adaptability: Adjusting to the Rapid Changes of the Scientific World
por: do Carmo, Andreia Cristina Feitosa, et al.
Publicado: (2023)

Human cytokine-induced killer cells have enhanced in vitro cytolytic activity via non-viral interleukin-2 gene transfer
por: Nagaraj, Srinivas, et al.
Publicado: (2004)

Dose adjustment for tyrosine kinase inhibitors in non-small cell lung cancer patients with hepatic or renal function impairment
por: Zhao, Dehua, et al.
Publicado: (2021)

No dose adjustment of tigecycline is necessary during continuous renal replacement therapy: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2020)

New Onset Non-Convulsive Status Epilepticus Despite Cefepime Renal Dose Adjustment
por: Oyenuga, Mosunmoluwa, et al.
Publicado: (2021)

Editorial: Neurolaw: The Call for Adjusting Theory Based on Scientific Results
por: Muñoz, José M., et al.
Publicado: (2020)

CIK Cells and HDAC Inhibitors in Multiple Myeloma
por: Stephan, David, et al.
Publicado: (2017)

Dose Adjustment Strategy of Cyclosporine A in Renal Transplant Patients: Evaluation of Anthropometric Parameters for Dose Adjustment and C0 vs. C2 Monitoring in Japan, 2001-2010
por: Kokuhu, Takatoshi, et al.
Publicado: (2013)

Primary small cell carcinoma of the esophagus: patient data metaanalysis and review of the literature
por: Al Mansoor, Saineb, et al.
Publicado: (2013)

Dose Recommendations for Common Drugs in Patients with Liver Cirrhosis: A Systematic Literature Review
por: Karsten Dafonte, Katharina, et al.
Publicado: (2023)

Clinical Decision Support System with Renal Dose Adjustment Did Not Improve Subsequent Renal and Hepatic Function among Inpatients: The Japan Adverse Drug Event Study
por: Wada, Ryuhei, et al.
Publicado: (2020)

Population PK/PD Model of Homocysteine Concentrations after High-Dose Methotrexate Treatment in Patients with Acute Lymphoblastic Leukemia
por: Rühs, Hauke, et al.
Publicado: (2012)

Novel phenotype with prominent cerebellar oculomotor dysfunction in spastic paraplegia type 39
por: Viertauer, Sebastian, et al.
Publicado: (2022)

Cytokine-induced killer cells are type II natural killer T cells
por: Gütgemann, Stefan, et al.
Publicado: (2007)

Increase of Antitumoral Effects of Cytokine-Induced Killer Cells by Antibody-Mediated Inhibition of MICA Shedding
por: Wu, Xiaolong, et al.
Publicado: (2020)

Hepatic mitochondrial dysfunction in fluid-resuscitated porcine septic shock
por: Wauters, J, et al.
Publicado: (2007)

Assessing the Risk of Nephrotoxicity Associated With Non-renally Adjusted Intravenous Polymyxin B Compared with Traditional Dosing
por: Maniara, Bejoy, et al.
Publicado: (2017)

Evaluation of renal drug dosing adjustment in chronic kidney disease patients at two university hospitals in Lebanon
por: Saad, Rayane, et al.
Publicado: (2019)

Efficacy and Safety of Cystatin C-Guided Renal Dose Adjustment of Cefepime Treatment in Hospitalized Patients with Pneumonia
por: Kim, Min-Chul, et al.
Publicado: (2020)

Drug dose adjustment in patients with renal impairment attending a specialized referral hospital, Northwest Ethiopia
por: Kassa Birarra, Mequanent, et al.
Publicado: (2022)

Are doses of lamotrigine or levetiracetam adjusted during pregnancy?
por: Richards, Noni, et al.
Publicado: (2017)

No Dose Adjustment for Isavuconazole Based on Age or Sex
por: Desai, Amit V., et al.
Publicado: (2019)

Critical Analysis of Apixaban Dose Adjustment Criteria
por: Vu, Anh, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kf6a8qcc0siutp60g4d4ctq8m3